These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8310097)

  • 1. [Atypical granulocytopenia in clozapine treatment].
    Hohl U; Hoffmann-Richter U
    Psychiatr Prax; 1993 Nov; 20(6):232-3. PubMed ID: 8310097
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hematologic effects of clozapine: evaluation of the international experience].
    Lamarque V
    Encephale; 1995 Jun; 21 Spec No 3():59-60. PubMed ID: 7628344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of clozapine-induced agranulocytosis with granulocyte colony-stimulating factor G-CSF].
    Heinz P; Müller H; Bauer M
    Psychiatr Prax; 1994 Mar; 21(2):81. PubMed ID: 7515190
    [No Abstract]   [Full Text] [Related]  

  • 4. Clozapine-associated agranulocytosis: risk and aetiology.
    Krupp P; Barnes P
    Br J Psychiatry Suppl; 1992 May; (17):38-40. PubMed ID: 1418887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine treatment after agranulocytosis induced by classic neuroleptics.
    Bauer M; Mackert A
    J Clin Psychopharmacol; 1994 Feb; 14(1):71-3. PubMed ID: 7908676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA's position on the clozaril patient management system.
    Peck CC
    Hosp Community Psychiatry; 1990 Aug; 41(8):876-7. PubMed ID: 2401475
    [No Abstract]   [Full Text] [Related]  

  • 7. [Patient knowledge regarding Clozapine-induced agranulocytosis].
    Haberfellner EM; Rittmannsberger H
    Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
    [No Abstract]   [Full Text] [Related]  

  • 8. Clozapine: the commitment to patient safety.
    Alphs LD; Anand R
    J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine alone versus clozapine and risperidone for refractory schizophrenia.
    Gerson SL
    N Engl J Med; 2006 Apr; 354(17):1846-8; author reply 1846-8. PubMed ID: 16642587
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of cytokines in clozapine-induced agranulocytosis.
    Chin-Yee I; Bezchlibnyk-Butler K; Wong L
    Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients.
    Swartz JR; Ananth J; Smith MW; Burgoyne KS; Gadasally R; Arai Y
    J Clin Psychiatry; 1999 Feb; 60(2):119-21. PubMed ID: 10084639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unsuccessful reexposure to clozapine.
    Frankenburg FR; Stormberg D; Gerson SL
    J Clin Psychopharmacol; 1994 Dec; 14(6):428-9. PubMed ID: 7884027
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of clozapine-induced agranulocytosis with granulocyte colony-stimulating factor.
    Raison CL; Guze BH; Kissell RL
    J Clin Psychopharmacol; 1994 Aug; 14(4):285-6. PubMed ID: 7525662
    [No Abstract]   [Full Text] [Related]  

  • 14. Sandoz guidelines for clozapine monitoring called too restrictive.
    Hosp Community Psychiatry; 1991 May; 42(5):545. PubMed ID: 2060927
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clozapine: an exclusive treatment?].
    Vanelle JM
    Encephale; 1992 Sep; 18 Spec No 3():441-5. PubMed ID: 1339761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of clozapine-induced granulocytopenia/agranulocytosis with granulocyte-colony stimulating factor (G-CSF) in an intellectually disabled patient with schizophrenia.
    Rajagopal G; Graham JG; Haut FF
    J Intellect Disabil Res; 2007 Jan; 51(Pt 1):82-5. PubMed ID: 17181606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on clozapine.
    Med Lett Drugs Ther; 1993 Feb; 35(890):16-8. PubMed ID: 8093972
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clozapine treatment in schizophrenia. A safety system is needed to prevent side effects].
    Lundström S; Persson P
    Lakartidningen; 1991 Jul; 88(30-31):2510-1. PubMed ID: 1865717
    [No Abstract]   [Full Text] [Related]  

  • 19. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
    Meged S; Stein D; Sitrota P; Melamed Y; Elizur A; Shmuelian I; Gazit E
    Int Clin Psychopharmacol; 1999 Sep; 14(5):305-12. PubMed ID: 10529073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S; Rosenius S; Spigset O
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.